Insider Transactions in Q1 2022 at Coherus Bio Sciences, Inc. (CHRS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
Mats Wahlstrom |
BUY
Grant, award, or other acquisition
|
Direct |
29,994
+42.85%
|
$59,988
$2.08 P/Share
|
|
Feb 25
2022
|
Mats Wahlstrom |
BUY
Grant, award, or other acquisition
|
Direct |
10,006
+50.0%
|
$110,066
$11.64 P/Share
|
|
Jan 11
2022
|
Vladimir Vexler Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,583
-3.23%
|
$50,162
$14.36 P/Share
|
|
Jan 10
2022
|
Vladimir Vexler Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,150
-3.6%
|
$58,100
$14.3 P/Share
|
|
Jan 04
2022
|
Vladimir Vexler Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.78%
|
-
|
|
Jan 04
2022
|
Mc David Stilwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+35.36%
|
-
|
|
Jan 04
2022
|
Dennis M Lanfear President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
86,250
+12.96%
|
-
|